Abstract: Tacrine, a well-known acetylcholinesterase inhibitor, applied in concentrations higher than 2×10
Introduction
The wide use of acetylcholinesterase inhibitors accounts for the unabated interest of pharmacologists, clinicians, and neurologists towards the representatives of this group. However, the anticholinesterase action is not the only pharmacological reaction responsible for their therapeutic effects.
Tacrine is an acetylcholinesterase inhibitor applied in the symptomatic treatment of Alzheimer's disease [1, 2] . The drug exerts diverse effects [3, 4] . Some of them are not related to the cholinergic system [5, 6] and may underlie various side effects. Tacrine molecule freely penetrates through cell membranes [7] . Тhat is why Reiner and McGeer [8] presume that some of the effects provoked by tacrine are not receptor-mediated but result from its direct influence over intracellular signaling pathways.
Numerous studies have shown that cholinesterase inhibitors stimulate the contractile activity of isolated gastric smooth muscles (SM) [9] and the motility of gastrointestinal (GI) tract [10] [11] [12] by raising the level of endogenous acetylcholine, which is a main excitatory neurotransmitter for the tract. Tacrine is not an exception to this rule. Our investigations [13] however, have shown that in contrast to most acetylcholinesterase inhibitors in experiments in vitro with gastric and intestinal SM above a certain concentration (1×10 -5 -3×10 -5 mol/l) it promotes a relaxation. Drugs that inhibit muscarinic receptors on gastrointestinal smooth muscles and nicotinic receptors on enteric nerve cells do not influence the amplitude of tacrine-induced relaxation [13] . This relaxation was not affected by preliminary treatments of muscle strips with tetrodotoxin (ТТХ), a nerve action potentials blocker, potassium channel blockers (charybdotoxin, apamin, tetraethylammonium, and 4-aminopyridine) [14] , and Ca 2+ antagonists [15] . Therefore, this relaxing effect of tacrine is Ca 2+ -independent. It is a result from the direct action of tacrine over the contractile apparatus of the gastrointestinal smooth muscles [14] . When applied in vivo (daily dose 0.5 mg/kg) the drug significantly influences the motility of GI tract, causing hypotension, inhibited peristaltic activity and retarded evacuatory kinetics [12, 16] . This influence, untypical of acetylcholinesterase inhibitors, indicates a significant presence of non-anticholinesterase mechanisms in the formation of the total drug effect and most likely accounts for its specific side effects on GI tract motility [12, 16, 17] .
Different authors take controversial standpoints regarding the nature and importance of the nonanticholinesterase effects of tacrine and the necessity of considering them during treatment with this drug. This requires differentiation between the types of effects, determining their contribution to the overall drug effect as well as studying in greater detail the mechanisms involved.
Having demonstrated that the major effect of tacrine applied at high concentrations is not cholinergic, in the present study we try to shed some light on the mechanisms involved in the tacrine-induced muscle relaxation, which may be helpful in overcoming its side effects on gastro-intestinal tract.
Experimental Procedures

Experimental animals and SM preparations
Adult male Wistar rats weighing 250-320 g (n=75) were used. The animals were housed in standard laboratory conditions; they had free access to food and tap water and a 12-h light/dark cycle. The experiments were carried out in conformity with the requirements of the European Convention (Helsinki, 1975, article 101, paragraph 5). The experimental design was approved by the Ethical Committee of the Medical University in Plovdiv, Bulgaria. The rats were decapitated under ether anesthesia. Circular gastric corpus SM preparations (12-13 mm long and 1.0-1.1 mm wide; without mucosa) were immediately dissected. The muscle strips were mounted in a 20-ml temperature-controlled tissue bath between a fixed glass holder and an isometric force transducer.
Recording of smooth muscle mechanical and bioelectrical activity
The contractile activity of SM preparations was recorded isometrically by Swema tensodetector (Stockholm, Sweden). The initial mechanical tension of the SM preparations was achieved by stretching the tension system, and had a value corresponding to a stretching force of 10 mN. The Krebs solution bathing the smooth muscle preparations was aerated with a mixture of 95% О 2 and 5% СО 2 and had pH 7.4 at 37°С. The tone level of the preparations observed after a 60-minute period of adaptation at stabilized spontaneous activity was accepted as the initial tonus.
The alterations in spontaneous mechanical activity and tonus were recorded toward this level by means of a Мicrotechna amplifier (Prague, Czech Republic) and recorded with a Linseis polygraph (Selb, Germany). During the adaptation period the Krebs solution was changed several times. The viability of SM preparations was tested periodically by treatment with 1×10 -6 mol/l acetylcholine.
The bioelectric activity of SM preparations was investigated by means of the single sucrose gap method with silver non-polarizable freshly chlorinated electrodes. Krebs, KCl and sucrose bathing solutions (37°С) were continuously aerated with a mixture of 95% О 2 and 5% СО 2 .
Drugs were applied by adding aliquots of their concentrated solutions to the tissue bath. The aliquots were between 0.5 and 1% of the total Krebs solution volume.
Drugs, chemicals, solutions
The following drugs and chemicals were used: tacrine, trifluoperazine, SQ22536 [9-(tetrahydro-2-furanyl)-9H-purin-6-amine], DMSO (dimethyl sulfoxide), forskolin, theophylline, KT5720 from Sigma (St. Louis, MO); acetylcholine from Dispersa (Baeschlin, Germany). The dry substances were dissolved in the solvent recommended by the producer immediately prior to the experiments.
The Krebs solution contained the following (in mM): NaCl -120; KCl -5.9; CaCl 2 -2.5; MgCl 2 -1.2; NaH 2 PO 4 -1.2; NaHCO 3 -15.4 and glucose -11.5. The preparation solution contained NaCl/KCl/CaCl 2 in a ratio of 27.2/1.1/1. All chemicals used to prepare both solutions were produced by Merck (Darmstadt, Germany). The pH value was measured by a microcomputer pH-meter, model 6201, produced by Jenco Еlectronics LTD (UK).
Statistical processing of the results
Data variability was analyzed using a specialized software SPSS, version 8.0 (SPSS Inc. Chicago, IL); results being expressed as means ± standard error of the mean (SEM). The statistically significant values were evaluated by Student's t-test at a significance level Р<0.05.
Results
Effects of tacrine on spontaneous bioelectric activity
Application of tacrine at a concentration of 5×10 -5 mol/l or 1×10 -4 mol/l did not alter the membrane potential value of SM preparations but changed the type of slow wave and the frequency of spike potentials (number of potentials/min). Original experimental records are shown in Figure 1 .
The changes in the bioelectric activity of gastric SM preparations (n=5), induced by 1×10 -4 mol/l of tacrine, are shown in Table 1 .
Effects of tacrine on contractile activity
At concentrations higher than 2×10 -5 mol/l (5×10 -5 and 1×10 -4 mol/l), tacrine promoted a relaxation of the SM preparations (Figure 2) . At the first application of tacrine in the tissue bath, the relaxation was generally preceded by a short-time contraction that did not occur in the applications to follow. The tonic relaxation reached values of 2.36±0.31 mN (n=15) and 2.94±0.54 mN (n=15) for the two concentrations respectively, and remained stable with time (in our experiments -for more than 3 h).
Influence of trifluoperazine on tacrine relaxation effect
The phenothiazine neuroleptic trifluoperazine, a dopamine D1 and D2 receptor blocker with central antiadrenergic, antidopaminergic, and minimal anticholinergic effects, acting also as calmodulin inhibitor [18] and modulator of sarcoplasmic reticulum Ca 2+ release [19] , applied at a concentration of 1×10 -5 mol/l, decreased the SM tonus by 1.65±0.51 mN. With this as background, the relaxation induced by 1×10 -4 mol/l of tacrine was 3.15±1.42 mN (n=6) and was reliably preserved as compared to the control (Figure 3 ).
Influence of cAMP signaling pathway on tacrine-promoted relaxation effect
Theophylline (2×10 -4 mol/l), a competitive nonselective phosphodiesterase inhibitor, which raises intracellular cAMP and activates PKA, had no effect on the amplitude of tacrine-induced relaxation (Table 2 ). In the presence of 1×10 -6 mol/l forskolin, an activator of adenylate cyclase, the relaxation effect promoted by 5×10 -5 mol/l tacrine was significantly reduced (P<0.001), as compared to the control tacrine-induced relaxation. Similarly, the inhibition of adenylate cyclase activity with 4×10 -5 mol/l of SQ22536 notably decreased the relaxation effect of tacrine (Table 2) .
KT5720, an inhibitor of protein kinase А (PKА), was applied as a solution in DMSO. The solvent itself induced a mild SM relaxation response and a tendency to reduce the effect of 5×10 -5 mol/l of tacrine. That is why the effect of the tacrine in the presence of KT5720 was compared to the muscle tonus in the presence of the same volume of DMSO as the volume of the added KT5720. The effect of tacrine on the contractility of SM was changed after application of KT5720. In about 75% of the preparations (n=9) this substance caused a muscle relaxation (Figure 4) significantly milder than the control tacrineinduced relaxation. In the remaining approximately 25% of the experimental setups there was no response to the treatment with KT5720.
Discussion
Tacrine inhibits spontaneous bioelectric SM activity without significant influence on the membrane potential value. The changes in the spike potentials show that tacrine inhibits Ca 2+ influx through the L-type Са 2+ channels [20] . The reduction of spike-linked Ca 2+ influx is one of the specific mechanisms leading to SM relaxation [21] , untypical for the mechanisms of action of the most anticholinesterase drugs [21, 11] .
Our previous studies have shown that the relaxation effect of tacrine at concentrations higher than 2×10 -5 mol/l had no related with modulation of cytosolic Са 2+ level of treated SM cells but probably with desensitization of the SM contractile apparatus to Са 2+ [14] . The sensitization (desensitization) states of the contractile apparatus and the resulting SM contraction (relaxation) are usually a function of the ratio between the activity of myosin light-chain kinase (MLCK) and myosin light chain phosphatase (MLCP). The activity of both enzymes is inhibited when they are phosphorylated by other protein kinases. The Ca 2+ /calmodulin-dependent protein kinase II (CaM KІІ) phosphorylates MLCK [22] , as well as the cAMP-activated protein kinase [23] .
The calmodulin activation of СaM KІІ provokes autophosphorylation between its subunits [24] . The ability to autophosphorylate (and activate, respectively) turns СaM KІІ into a somewhat Са 2+ -independent enzyme [25] . This makes it a potential candidate for phosphorylation and MLCK inactivation and initiation of tacrine-induced Са 2+ -independent relaxation [26] . Being a calmodulin antagonist, trifluoperazine inhibits СaM KІІ activity and the potential processes in which it is involved [27] . In the present experiments trifluoperazine did not have an effect on the amplitude of tacrine-induced relaxation, which indicates a lack of direct participation of the enzyme in the processes studied.
The experimental results indicate that a rise in the сАМР level in SM tissues [28] is the major stimulus for relaxation. Inhibition of phosphodiesterase activity in neurons has been pointed out as a basic mechanism through which tacrine increases the сАМР level [29] . However, theophylline did not influence the tacrineinduced SM relaxation in our experiments. This observation eliminates phosphodiesterase as a potential participant in the discussed processes. At the same time the significant forskolin effectiveness on the tacrinepromoted relaxation can be accepted as an indication that the leading mechanism in SM relaxation is the increase in the сАМР level as a result from tacrine-stimulated adenylate cyclase activity. Data from experiments carried out in the presence of SQ22536, an adenylate cyclase blocker [30] , support such an assumption. The decrease of tacrine-induced relaxation is a consequence of the impossibility of the drug to further activate the adenylate cyclase, which has been previously activated by forskolin or to activate the enzyme already inhibited by SQ22536.
It is generally accepted that cAMP decreases the sensitivity of the SM contractile apparatus to Са 2+ and can induce relaxation through inhibition of actin-myosin interaction and cross bridge formation, because of phosphorylation and MLCK inactivation [31] or MLCP activation [31, 32] . These effects result from the action of the cAMP-dependent PКА on the above-mentioned enzymes [31, 33, 34] . The presence of KT5720, the specific inhibitor of PКА [35] , significantly minimizes tacrine-induced relaxation. This finding confirms a participation of PКА in the processes studied.
The reduction of Са
2+ influx in the presence of tacrine at concentrations above 2×10 -5 mol/l, recorded by decrease in spike potentials, also contributes to the development and progression of the tacrine-induced relaxation. This is likely to be a secondary process caused by the cAMP increase in SM cells. It is generally assumed that сАМР and PКА influence on the L-type Са 2+ channels of SM cells. The effect is largely influenced by the type of tissues studied and the cAMP concentration; however, the precise mechanism is unclear [36] . Most researchers are of the opinion that following phosphorylation of the Са 2+ channel proteins by PKA [36] [37] [38] an inhibition of the currents through them is recorded -an effect similar to that observed in our experiments.
In conclusion, the leading mechanism initiating tacrine relaxation effect is an increase in the cytosolic cAMP level. This is a Са 2+ -independent process, most likely linked with PKA-induced phosphorylation and inhibition of MLCK activity. As a secondary process, part of the tacrine-induced relaxation is caused by a Са 2+ -dependent pathway, which is provoked by cAMP. It acts through inhibition of the L-type membrane Са 2+ channels (probably after their phosphorylation by PKA) with resultant reduction of the cytosolic Са 2+ level in SM cells. Іt has been shown that betaamyloid monomers are able to activate L-type Ca 2+ channels in various types of neurons within the CNS and this may cause disruptions in neuronal signaling in the early stages of Alzheimer's disease [39] . In this respect, the influence of tacrine on the signaling cascade AC-cAMP-PKA and the inhibition of L-type Ca 2+ channels can be considered as a putative protective mechanism, beyond the well-known acetylcholinesterase inhibition.
